Tectonic Therapeutic, Inc. Quarterly Operating Income (Loss) in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tectonic Therapeutic, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2017 to Q2 2024.
  • Tectonic Therapeutic, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$11.4M, a 7.43% decline year-over-year.
  • Tectonic Therapeutic, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $26.7M.
  • Tectonic Therapeutic, Inc. annual Operating Income (Loss) for 2023 was $10.2M.
  • Tectonic Therapeutic, Inc. annual Operating Income (Loss) for 2022 was -$105M, a 11.3% increase from 2021.
  • Tectonic Therapeutic, Inc. annual Operating Income (Loss) for 2021 was -$119M, a 1.15% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $26.7M -$11.4M -$790K -7.43% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $27.5M -$7.94M +$17.3M +68.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.2M $69M +$94.2M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$84M -$22.9M +$52K +0.23% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$84.1M -$10.6M +$17.1M +61.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$101M -$25.2M +$4.2M +14.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$105M -$25.3M +$2.71M +9.67% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$108M -$23M +$9.64M +29.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$118M -$27.8M +$3.6M +11.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$121M -$29.4M -$2.53M -9.43% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$119M -$28M +$102K +0.36% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$119M -$32.6M +$4.1M +11.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$123M -$31.4M -$2.52M -8.73% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$121M -$26.9M -$295K -1.11% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$120M -$28.1M -$4.63M -19.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$116M -$36.7M -$18.7M -103% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$96.9M -$28.9M -$12.2M -73.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$84.7M -$26.6M -$8.89M -50.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$75.8M -$23.4M -$6.76M -40.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$69.1M -$18.1M -$5.83M -47.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$63.2M -$16.6M -$7.07M -74% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$56.2M -$17.7M -$9.91M -127% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$46.2M -$16.7M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$12.2M -$5.86M -92% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$9.55M -$7.01M -276% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$7.79M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q3 2017 -$6.37M Jun 24, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$2.54M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.